A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVIDStefanie M. Bader, David Komander, Yelena Khakham et al.|Nature Communications|2025Cited by 35
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivoStefanie M. Bader, Marcel Doerflinger, James P. Cooney et al.|Cell Death and Disease|2024Cited by 14
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivoJames P. Cooney, Marc Pellegrini, Ashley Hirons et al.|Cell|2025Cited by 14
Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infectionStefanie M. Bader, Marcel Doerflinger, L.R. Scherer et al.|Nature Communications|2025Cited by 4
A novel PLpro inhibitor scaffold that protects mice from Long-COVIDDavid Komander, Guillaume Lessène, Marcel Doerflinger et al.|Research Square|2024Cited by 1